Electrophysiological characteristics of cells in the anterior caudal lobe of the mormyrid cerebellum.
We have examined the basic electrophysiology and pharmacology of cells in the anterior caudal lobe (CLa) of the mormyrid cerebellum. Intracellular recordings were performed in an in vitro slice preparation using the whole-cell patch recording method. The responses of cells to parallel fiber (PF) and climbing fiber (CF) stimulation and to somatic current injection were recorded, and then characterized by bath application of receptor and ion channel blockers. Using biocytin or neurobiotin, these cells were also morphologically identified after recording to ensure their classification. Efferent cells and two subtypes of Purkinje cells were identified on the basis of their physiology and morphology. While the majority of Purkinje cells fire a single type of spike that is mediated by Na(+), some fire a large broad spike mediated by Ca(2+) and a narrow spike mediated by Na(+) at resting potential levels. By patching one recording electrode to the soma and another to one of the proximal dendrites of the same cell simultaneously, it was found that the Na(+) spike has an axonal origin and the Ca(2+) spike is generated in the soma-dendritic region of Purkinje cells. Efferent cells fire a single type of Na(+) spike only. Despite variations in their physiology and morphology, all cell types responded to PF stimulation with graded excitatory postsynaptic potentials (EPSPs) mediated by AMPA receptors. However, none of the efferent cells and only some of the Purkinje cells responded to CF activation with a large, AMPA receptor-mediated all-or-none EPSPs. We conclude that the functional circuitry of the CLa resembles that of other regions of the mormyrid cerebellum and is largely similar to that of the mammalian cerebellum.
Zhang
Y
Y
Center for Integrative Brain Research, Seattle Children's Hospital Research Institute, Seattle, WA 98101, USA.
Magnus
G
G
Han
V Z
VZ
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology; D000818:Animals; D001369:Axons / Q000187:drug effects; D001703:Biophysics; D002531:Cerebellum / Q000166:cytology*; D003712:Dendrites / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004555:Electric Fish / Q000033:anatomy & histology*; D004558:Electric Stimulation; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects / Q000502:physiology; D066298:In Vitro Techniques; D008239:Lysine / Q000031:analogs & derivatives / Q000378:metabolism; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D016202:N-Methylaspartate / Q000494:pharmacology; D009412:Nerve Fibers / Q000502:physiology; D018408:Patch-Clamp Techniques; D011689:Purkinje Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D026941:Sodium Channel Blockers / Q000494:pharmacology; D013779:Tetrodotoxin / Q000494:pharmacology
D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; D026941:Sodium Channel Blockers; D013779:Tetrodotoxin; D016202:N-Methylaspartate; D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; C013411:biocytin; D008239:Lysine